Platinum-based Drugs Market By Type (Cisplatin, Oxaliplatin, Carboplatin, and Other), By Application (Colorectal Cancer, Ovarian Cancer, Lung Cancer, and Other), and By Region, Trends, Analysis and Forecast till 2030

An increase in the cancer prevalence

Growing rates of cancer are one of the main factors propelling the global market for medications based on platinum. According to a National Cancer Institute estimate, by 2030 there would be 23.6 million new instances of cancer annually. The market for platinum-based cancer medications has seen significant advancements, such as the creation of analog platinum medications and platinum carrier molecule complexes to increase the precise concentration of medications in cancerous tumors. The World Health Organization (WHO) research indicates that cancer is the second leading cause of death globally, with predictions of 9.6 million fatalities in 2018. Of those deaths, 2.09 million are expected to be due to lung cancer.